Volume 13, Number 3—March 2007
Dispatch
Clostridium difficile in Retail Ground Meat, Canada
Alexander Rodriguez-Palacios*
, Henry R. Staempfli*, Todd Duffield*, and J. Scott Weese*
, Henry R. Staempfli*, Todd Duffield*, and J. Scott Weese*
Table 2
Drug resistance characteristics of 12 meat-derived Clostridium difficile isolates determined by E-test on Muller-Hinton agar after 48 h of incubation*
| Antimicrobial drug | MIC50, μg/mL | MIC90, μg/mL | Range, μg/mL | % Resistant isolates |
|---|---|---|---|---|
| Vancomycin | 0.5 | 0.75 | 0.5 to 1.0 | 0 |
| Metronidazole | 0.38 | 0.5 | 0.19 to 1.0 | 0 |
| Levofloxacin | 32 | 32 | 4 to >32 | 100 |
| Clindamycin | 16.0 | 24.0 | 8 to >256 | 100 |
*Breakpoints used were vancomycin susceptible, <4.0 μg/mL; vancomycin resistant >32.0 μg/mL; metronidazole susceptible, <8.0 μg/mL; metronidazole resistant, >32.0 μg/mL; clindamycin susceptible, <2.0 μg/mL; clindamycin resistant >8.0 μg/mL; levofloxacin susceptible, <2.0 μg/mL; levofloxacin resistant, >8.0 μg/mL.
Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.